Yingke medical: it plans to invest 130 million yuan in Changzhou Yunchang
Financial Associated Press, Nov. 19 - Yingke medical announced that Yingke Hong Kong, an overseas wholly-owned subsidiary of the company, plans to subscribe and establish qflp through the qualified overseas limited partner ("qflp") mechanism, that is, Guangxi Yunzhuang. Guangxi Yunzhuang will participate in the investment in the RMB phase III fund managed by Shanghai yunpan as one of the limited partners, that is, Changzhou Yunchang and other partnerships investing in parallel. The target total subscribed capital of the partnership is RMB 1.2 billion, and the company will subscribe RMB 130 million to invest in the partnership through Guangxi Yunzhuang.
This text is a result of machine translation.
Related companies：
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jan 14, 2022 01:18 PM
· Healthcare
Mask protection unit rose in the afternoon
Briefing Jul 21, 2021 03:11 PM
The latest position of Qu Yang, fund manager of Qianhai open source: Hong Kong stocks redistributed, Tencent holdings and BYD holdings increased
Briefing Jul 14, 2021 07:40 PM
Global supply of gloves may be blocked due to the outbreak in Malaysia, Yingke medical said it has received some transfer orders
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Yesterday 02:21 PM
Insight
In-depth